These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22100760)

  • 1. Sera from neuromyelitis optica patients disrupt the blood-brain barrier.
    Shimizu F; Sano Y; Takahashi T; Haruki H; Saito K; Koga M; Kanda T
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):288-97. PubMed ID: 22100760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
    Tasaki A; Shimizu F; Sano Y; Fujisawa M; Takahashi T; Haruki H; Abe M; Koga M; Kanda T
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):419-30. PubMed ID: 24259591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement.
    Haruki H; Sano Y; Shimizu F; Omoto M; Tasaki A; Oishi M; Koga M; Saito K; Takahashi T; Nakada T; Kanda T
    J Neurol Sci; 2013 Aug; 331(1-2):136-44. PubMed ID: 23809190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.
    Shimizu F; Nishihara H; Sano Y; Takeshita Y; Takahashi S; Maeda T; Takahashi T; Abe M; Koga M; Kanda T
    PLoS One; 2015; 10(3):e0122000. PubMed ID: 25811465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.
    Shimizu F; Schaller KL; Owens GP; Cotleur AC; Kellner D; Takeshita Y; Obermeier B; Kryzer TJ; Sano Y; Kanda T; Lennon VA; Ransohoff RM; Bennett JL
    Sci Transl Med; 2017 Jul; 9(397):. PubMed ID: 28679661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disruption of blood-brain barrier in multiple sclerosis and neuromyelitis optica].
    Shimizu F; Kanda T
    Nihon Rinsho; 2014 Nov; 72(11):1949-54. PubMed ID: 25518376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study.
    Saito K; Shimizu F; Koga M; Sano Y; Tasaki A; Abe M; Haruki H; Maeda T; Suzuki S; Kusunoki S; Mizusawa H; Kanda T
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):756-65. PubMed ID: 23584494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
    Uchida T; Mori M; Uzawa A; Masuda H; Muto M; Ohtani R; Kuwabara S
    Mult Scler; 2017 Jul; 23(8):1072-1084. PubMed ID: 27682231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disruption of the blood-brain barrier in inflammatory neurological diseases].
    Shimizu F; Kanda T
    Brain Nerve; 2013 Feb; 65(2):165-76. PubMed ID: 23399674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
    Matsumoto Y; Kanamori A; Nakamura M; Takahashi T; Nakashima I; Negi A
    Exp Eye Res; 2014 Feb; 119():61-9. PubMed ID: 24374258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
    Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
    J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier.
    Shimizu F; Omoto M; Sano Y; Mastui N; Miyashiro A; Tasaki A; Maeda T; Koga M; Kaji R; Kanda T
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):526-37. PubMed ID: 23926278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
    Shimizu F; Tasaki A; Sano Y; Ju M; Nishihara H; Oishi M; Koga M; Kawai M; Kanda T
    PLoS One; 2014; 9(3):e92872. PubMed ID: 24686948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
    Nishihara H; Shimizu F; Sano Y; Takeshita Y; Maeda T; Abe M; Koga M; Kanda T
    PLoS One; 2015; 10(3):e0121488. PubMed ID: 25774903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica.
    Isobe N; Yonekawa T; Matsushita T; Kawano Y; Masaki K; Yoshimura S; Fichna J; Chen S; Furmaniak J; Smith BR; Kira J
    Mult Scler; 2012 Nov; 18(11):1541-51. PubMed ID: 22526930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
    Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
    J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.